Sign up to save your podcasts
Or
Share Billion Dollar Bets: Lessons on Innovation from a BMS Chief Scientific Officer, Dr. Elliott Sigal (Ep. 4 of The Pharmcast)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Billion Dollar Bets: Lessons on Innovation from a BMS Chief Scientific Officer, Dr. Elliott Sigal (Ep. 4 of The Pharmcast)
This week in The Pharmcast, we catch up with Dr. Elliott Sigal, former Chief Scientific Officer of Bristol-Myers Squibb.
In 2012, The Wall Street Journal called Dr. Sigal "The Best R&D Chief in Pharma," largely for helping deliver BMS' "String of Pearls" strategy that helped position BMS as a major player in the immuno-oncology space.
In Episode 4 of the Pharmcast, we talk with Dr. Sigal about leadership, portfolio decisions and what made him successful on his journey.
View all episodes
By YourEncore, Inc.This week in The Pharmcast, we catch up with Dr. Elliott Sigal, former Chief Scientific Officer of Bristol-Myers Squibb.
In 2012, The Wall Street Journal called Dr. Sigal "The Best R&D Chief in Pharma," largely for helping deliver BMS' "String of Pearls" strategy that helped position BMS as a major player in the immuno-oncology space.
In Episode 4 of the Pharmcast, we talk with Dr. Sigal about leadership, portfolio decisions and what made him successful on his journey.